Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives, Tesla ...

Wedbush maintained its Outperform rating on Apple (NASDAQ:AAPL) noting that the company's next stage of product and AI driven services growth is still ahead. The firm has a $325 price target on ...

As previously reported, Wedbush upgraded National CineMedia (NCMI) to Outperform from Neutral with a $7.50 price target The firm believes the company stands to gain from a strong box office ...

Wedbush analysts are staying bullish on AI-driven tech stocks, arguing that the recent market pullback is temporary and that industry leaders could reach new highs in the second half of 2025.

Jeff Daniels has joined the cast of “Shrinking” at Apple TV+, Variety has learned. The actor will appear in the series’ upcoming third season, which was originally announced in October 2024.

In a report released today, David Nierengarten from Wedbush maintained a Hold rating on Fate Therapeutics (FATE – Research Report), with a price target of $5.00. See what stocks are receiving ...

Jeff Bezos and Lauren Sanchez are set to tie the knot in summer 2025, with reports suggesting a grand, no-expense-spared wedding. (File photo)(REUTERS) Amazon founder Jeff Bezos and his fiancée ...

Washington Post owner Jeff Bezos on Wednesday announced a “significant shift” to the publisher’s opinion page that led David Shipley, the paper’s editorial page editor, to leave the paper.

Wedbush currently has a $325.00 price target on the iPhone maker’s stock. AAPL has been the subject of several other research reports. Barclays boosted their price target on shares of Apple from ...

Wedbush became the latest brokerage to downgrade Arvinas (NASDAQ:ARVN) on Wednesday after the company posted underwhelming late-stage trial data for vepdegestrant, an experimental breast cancer ...

Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Wedbush issued their FY2024 EPS estimates for shares of Tourmaline Bio in a research note issued on Thursday, March 6th.

Jeff Bezos is exerting more influence over the content of the Washington Post opinion pages, as he announced Wednesday that its editorials will now focus on “defense of two pillars: personal ...